CureVac Statistics

Share Statistics

CureVac has 225.17M shares outstanding. The number of shares has increased by 0.39% in one year.

Shares Outstanding	225.17M
Shares Change (YoY)	0.39%
Shares Change (QoQ)	0.39%
Owned by Institutions (%)	3.51%
Shares Floating	95.5M
Failed to Deliver (FTD) Shares	138,261
FTD / Avg. Volume	11.11%

Short Selling Information

The latest short interest is 1.06M, so 0.47% of the outstanding shares have been sold short.

Short Interest	1.06M
Short % of Shares Out	0.47%
Short % of Float	2.64%
Short Ratio (days to cover)	1.17

Valuation Ratios

The PE ratio is 4.56 and the forward PE ratio is -10.67. CureVac's PEG ratio is -0.03.

PE Ratio	4.56
Forward PE	-10.67
PS Ratio	1.38
Forward PS	12.7
PB Ratio	1.06
P/FCF Ratio	8.86
PEG Ratio	-0.03

Financial Ratio History

Enterprise Valuation

CureVac has an Enterprise Value (EV) of 296.1M.

EV / Sales	0.55
EV / EBITDA	1.41
EV / EBIT	2.91
EV / FCF	3.55

Financial Position

The company has a current ratio of 7.28, with a Debt / Equity ratio of 0.06.

Current Ratio	7.28
Quick Ratio	7.27
Debt / Equity	0.06
Debt / EBITDA	0.19
Debt / FCF	0.47
Interest Coverage	0

Financial Efficiency

Return on Equity is 23.28% and Return on Invested Capital is 20.52%.

Return on Equity	23.28%
Return on Assets	20.2%
Return on Invested Capital	20.52%
Revenue Per Employee	$648.7K
Profits Per Employee	$196.59K
Employee Count	825
Asset Turnover	0.67
Inventory Turnover	195.62

Taxes

Income Tax	28.7M
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by 66.77% in the last 52 weeks. The beta is 2.53, so CureVac's price volatility has been higher than the market average.

Beta	2.53
52-Week Price Change	66.77%
50-Day Moving Average	5.24
200-Day Moving Average	3.75
Relative Strength Index (RSI)	57.23
Average Volume (20 Days)	1,244,646

Income Statement

In the last 12 months, CureVac had revenue of 535.18M and earned 162.19M in profits. Earnings per share was 0.72.

Revenue	535.18M
Gross Profit	429.35M
Operating Income	177.68M
Net Income	162.19M
EBITDA	209.69M
EBIT	190.88M
Earnings Per Share (EPS)	0.72

Full Income Statement

Balance Sheet

The company has 481.75M in cash and 38.97M in debt, giving a net cash position of 442.78M.

Cash & Cash Equivalents	481.75M
Total Debt	38.97M
Net Cash	442.78M
Retained Earnings	-1.4B
Total Assets	742.27M
Working Capital	407.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 101.85M and capital expenditures -18.44M, giving a free cash flow of 83.41M.

Operating Cash Flow	101.85M
Capital Expenditures	-18.44M
Free Cash Flow	83.41M
FCF Per Share	0.37

Full Cash Flow Statement

Margins

Gross margin is 80.23%, with operating and profit margins of 33.2% and 30.3%.

Gross Margin	80.23%
Operating Margin	33.2%
Pretax Margin	35.67%
Profit Margin	30.3%
EBITDA Margin	39.18%
EBIT Margin	33.2%
FCF Margin	15.58%

Dividends & Yields

CVAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	21.95%
FCF Yield	11.29%

Dividend Details

Analyst Forecast

The average price target for CVAC is $5.5, which is 1.5% higher than the current price. The consensus rating is "Hold".

Price Target	$5.5
Price Target Difference	1.5%
Analyst Consensus	Hold
Analyst Count	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	7.11
Graham Upside	31.18%

Scores

Altman Z-Score	7.27
Piotroski F-Score	6

CureVac N.V. (CVAC)